333 related articles for article (PubMed ID: 24506594)
1. Limitations of the TG-43 formalism for skin high-dose-rate brachytherapy dose calculations.
Granero D; Perez-Calatayud J; Vijande J; Ballester F; Rivard MJ
Med Phys; 2014 Feb; 41(2):021703. PubMed ID: 24506594
[TBL] [Abstract][Full Text] [Related]
2. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
[TBL] [Abstract][Full Text] [Related]
3. Comparison of
Safigholi H; Meigooni AS; Song WY
Med Phys; 2017 Sep; 44(9):4426-4436. PubMed ID: 28494095
[TBL] [Abstract][Full Text] [Related]
4. The validity of Acuros BV and TG-43 for high-dose-rate brachytherapy superficial mold treatments.
Boman EL; Satherley TWS; Schleich N; Paterson DB; Greig L; Louwe RJW
Brachytherapy; 2017; 16(6):1280-1288. PubMed ID: 28967561
[TBL] [Abstract][Full Text] [Related]
5. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate
Ma Y; Vijande J; Ballester F; Tedgren ÅC; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith R; Chamberland MJP; Thomson RM; Verhaegen F; Beaulieu L
Med Phys; 2017 Nov; 44(11):5961-5976. PubMed ID: 28722180
[TBL] [Abstract][Full Text] [Related]
6. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
Poon E; Verhaegen F
Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
[TBL] [Abstract][Full Text] [Related]
7. Performance evaluation of a collapsed cone dose calculation algorithm for HDR Ir-192 of APBI treatments.
Terribilini D; Vitzthum V; Volken W; Frei D; Loessl K; van Veelen B; Manser P; Fix MK
Med Phys; 2017 Oct; 44(10):5475-5485. PubMed ID: 28750134
[TBL] [Abstract][Full Text] [Related]
8. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
Selvam TP; Sahoo S; Vishwakarma RS
Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
[TBL] [Abstract][Full Text] [Related]
9. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
Bannon EA; Yang Y; Rivard MJ
Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part I: single sources and bounded homogeneous geometries.
Zourari K; Pantelis E; Moutsatsos A; Petrokokkinos L; Karaiskos P; Sakelliou L; Georgiou E; Papagiannis P
Med Phys; 2010 Feb; 37(2):649-61. PubMed ID: 20229874
[TBL] [Abstract][Full Text] [Related]
11. A revised dosimetric characterization of
Abdollahi S; Dayyani M; Hoseinian-Azghadi E; Miri-Hakimabad H; Rafat-Motavalli L
Brachytherapy; 2018; 17(6):1011-1022. PubMed ID: 30227978
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo calculation of the TG-43 dosimetric parameters of a new BEBIG Ir-192 HDR source.
Granero D; Pérez-Calatayud J; Ballester F
Radiother Oncol; 2005 Jul; 76(1):79-85. PubMed ID: 16019091
[TBL] [Abstract][Full Text] [Related]
13. Transit dose comparisons for
Giménez-Alventosa V; Vijande J; Ballester F; Perez-Calatayud J
J Radiol Prot; 2016 Dec; 36(4):858-864. PubMed ID: 27739408
[TBL] [Abstract][Full Text] [Related]
14. Comparison of TG-43 and TG-186 in breast irradiation using a low energy electronic brachytherapy source.
White SA; Landry G; Fonseca GP; Holt R; Rusch T; Beaulieu L; Verhaegen F; Reniers B
Med Phys; 2014 Jun; 41(6):061701. PubMed ID: 24877796
[TBL] [Abstract][Full Text] [Related]
15. RapidBrachyTG43: A Geant4-based TG-43 parameter and dose calculation module for brachytherapy dosimetry.
Kalinowski J; Enger SA
Med Phys; 2024 May; 51(5):3746-3757. PubMed ID: 38252746
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric characterization of the GammaClip™ 169Yb low dose rate permanent implant brachytherapy source for the treatment of nonsmall cell lung cancer postwedge resection.
Currier B; Munro JJ; Medich DC
Med Phys; 2013 Aug; 40(8):080701. PubMed ID: 23927294
[TBL] [Abstract][Full Text] [Related]
17. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
18. Monte Carlo dosimetry of 60Co HDR brachytherapy sources.
Papagiannis P; Angelopoulos A; Pantelis E; Sakelliou L; Karaiskos P; Shimizu Y
Med Phys; 2003 Apr; 30(4):712-21. PubMed ID: 12722823
[TBL] [Abstract][Full Text] [Related]
19. Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation.
Beaulieu L; Carlsson Tedgren A; Carrier JF; Davis SD; Mourtada F; Rivard MJ; Thomson RM; Verhaegen F; Wareing TA; Williamson JF
Med Phys; 2012 Oct; 39(10):6208-36. PubMed ID: 23039658
[TBL] [Abstract][Full Text] [Related]
20. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
